跳至主要内容
临床试验/NCT05396599
NCT05396599终止不适用

A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.

Johnson & Johnson Surgical Vision, Inc.10 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
35
试验地点
10
主要终点
Rotational Stability of IOL

研究概览

简要总结

This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible subjects will be enrolled based on surgeon's determination of meeting the minimum study criteria in one or both eyes:
  • Male or female at least 22 years of age
  • Have a cataract in one or both eyes, with planned phacoemulsification and intraocular lens implantation with a toric intraocular lens
  • Regular corneal astigmatism and predicted postoperative residual astigmatism of less than 1.00 D after implantation with a toric intraocular lens in the study eye(s)
  • Availability, willingness and sufficient cognitive awareness to understand the purpose of the examination procedures and comply with postoperative visits
  • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.

排除标准

  • Eligible subjects will be enrolled based on surgeon's determination of meeting the minimum study criteria in one or both eyes:
  • Best-corrected distance visual acuity better than 20/40 Snellen (0.3 logMAR)
  • Potential visual acuity estimated to be worse than 20/32 Snellen (0.2 logMAR)
  • Prior corneal refractive (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery, Including prophylactic peripheral iridotomies and peripheral laser retinal repairs
  • Corneal abnormalities such as stromal, epithelial or endothelial dystrophies (e.g., any observed guttata) that are predicted to cause visual acuity losses to a level worse than 20/30 Snellen during the study
  • Pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils) or unable to dilate to visualize IOL axis (approximately 6.0 mm)
  • Inability to achieve keratometric stability for contact lens wearers (as defined in Section 10.3 Preoperative Procedures)
  • Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject
  • Use of systemic or ocular medications that may affect vision
  • Prior, current, or anticipated use during the course of the 6-month study of tamsulosin or silodosin (e.g., Flomax, Flomaxtra, Rapaflo) that may, in the opinion of the investigator, confound the outcome or increase the risk to the subject (e.g., poor dilation or a lack of adequate iris structure to perform standard cataract surgery)
  • Poorly controlled diabetes
  • Acute, chronic, or uncontrolled systemic or ocular disease or illness that, in the opinion of the investigator, would increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, suspected glaucoma, glaucomatous changes in the fundus or visual field, ocular inflammation, etc.). Note: controlled ocular hypertension without glaucomatous changes (optic nerve cupping and visual field loss) is acceptable.
  • Pregnancy, planned pregnancy, presently lactating, or another condition associated with hormonal fluctuation that could lead to refractive changes
  • Concurrent participation or participation in any other clinical study within 30 days prior to the preoperative visit
  • Any other systemic or ocular disease that, in the opinion of the investigator, may affect the patient's eligibility for the study, affect visual acuity or may require surgical intervention during the study (e.g., macular degeneration, cystoid macular edema, diabetic retinopathy, etc.).

结局指标

主要结局

Rotational Stability of IOL

时间窗: 1 month

The percentage of eyes with rotational stability of the IOL at postoperative 1 month.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验